Company to send 12 million doses of COVID-19 vaccine adapted to target Omicron.
Moderna is supplying Canada with 12 million COVID-19 shots specifically designed to target the Omicron variant of COVID-19.
Last year, the Canadian government entered into a supply deal with the company for supply of its COVID vaccine for 2022 and 2023.
The contract does allow for access to new adaptations of the vaccine.
Moderna and Canada have agreed to convert six million doses of the company's COVID vaccine, which targets the original virus, to an Omicron-containing bivalent one.
The country will also purchase an addition 4.5 million doses of the Omicron-targeted shot, and is moving forward with a scheduled delivery of 1.5 million shots of the bivalent vaccine.
While existing COVID-19 inoculations continue to provide protections against hospitalization and death, experts say the effectiveness of the vaccine has decreased as the virus has evolved.
Chief Public Health Officer Dr. Theresa Tam says Health Canada is still reviewing submissions for bivalent vaccines from Moderna and Pfizer.

SWPH Reports High Influenza Risk
Deputy Warden Appointed for 2026
Handbags for Hospice to Shimmer for Sakura House
Beachville Museum Employee Receives Award
SWPH Issues Cold Weather Alert
Oxford OPP Briefs - Dec. 15th 2025
White Christmas Not Guaranteed for Oxford
PJHL Recap - Dec 12th to Dec 14th
Holiday Safety Tips from OCAR
Paris Man Charged with Impaired
Rob Reiner Dead at 78
Christmas Lights Stolen in Ingersoll
UPDATE: Cyber Security Experts Investigating Oxford Incident
PJHL Preview - Dec. 12th to Dec. 14th
Tour of Lights Begins this Weekend
Drunk Drivers Charged in Woodstock
Week Three Results for Festive RIDE Campaign
Woodstock Passes 2026 Capital Budget
WFD Respond to Two Fires in the City
An Impaired Driver was Caught in EZT
Comments
Add a comment